Mental disorders

• Relationship between cannabis use frequency and major depressive disorder in adolescents: findings from the National Survey on Drug Use and Health 2012–2017 (30 Sep 2024)
  
• The therapeutic role of Cannabidiol in mental health: a systematic review (24 Sep 2024)
  
• Introduction to Cannabis Special Issue (24 Sep 2024)
  
• Association of early onset of cannabis, cigarette, other drug use and schizophrenia or psychosis (16 Sep 2024)
  
• The Impacts of Adolescent Cannabinoid Exposure on Striatal Anxiety- and Depressive-Like Pathophysiology Are Prevented by the Antioxidant N-Acetylcysteine (02 Sep 2024)
  
• Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study (02 Sep 2024)
  
• DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use? (02 Sep 2024)
  
• Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders (29 Aug 2024)
  
• Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients (18 Aug 2024)
  
• Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy (18 Aug 2024)
  
• First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone (12 Aug 2024)
  
• Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry (05 Sep 2022)